Arterial wall injury in giant cell arteritis

Arthritis and Rheumatism

Volumn 42, Issue 5, 1999, Pages 844-853

  Weyand, Cornelia M ^a   Goronzy, Jörg J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTERY INJURY; ARTERY WALL; GIANT CELL ARTERITIS; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ARTERIES; ENDOTHELIUM, VASCULAR; HUMANS; TEMPORAL ARTERITIS;

EID: 0032946689     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M     Document Type: Review

References (74)

1. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995; 57:791-804.
2. Lie JT, and members and consultants of the American College of Rheumatology Subcommittee on Classification of Vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074-87.
3. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
4. Weyand CM, Goronzy JJ. Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis. Curr Opin Rheumatol 1995;7:30-6.
5. Weyand CM, Goronzy JJ. Multisystem interactions in the pathogenesis of vasculitis. Curr Opin Rheumatol 1997;9:3-11.
6. Lie JT. Histopathologic specificity of systemic vasculitis. Rheum Dis Clin North Am 1995;21:883-909.
7. Martinez-Taboada V, Brack A, Hunder GG, Goronzy JJ, Weyand CM. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol 1996;23:1011-4.
8. Weyand CM, Schonberger J, Oppitz U, Hunder NN, Hicok KC, Goronzy JJ. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med 1994;179:951-60.
9. Martinez-Taboada V, Hunder NN, Hunder GG, Weyand CM, Goronzy JJ. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J Mol Med 1996;74:695-703.
10. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;121:484-91.
11. Weyand CM, Tetzlaff N, Björnsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26.
12. Hayreh SS. Anterior ischemic optic neuropathy. Clin Neurosci 1997;4:251-63.
13. Moore PM. Central nervous system vasculitis. Curr Opin Neurol 1998;11:241-6.
14. Kaiser M, Weyand CM, Björnsson J, Goronzy JJ. Platelet-derived growth factor, intimai hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998;41:623-33.
15. Kaiser M, Goronzy JJ, Weyand CM. Neoangiogenesis in response to inflammatory vascular injury [abstract]. Arthritis Rheum 1998;41 Suppl 9:S347.
16. Weyand CM, Goronzy JJ. Giant cell arteritis as an antigen-driven disease. Rheum Dis Clin North Am 1995;21:1027-39.
17. Weyand CM, Goronzy JJ. The pathogenic role of T lymphocytes in vasculitis. Sarcoidosis Vase Diffuse Lung Dis 1996;13:217-20.
18. Brack A, Genestier L, Martinez-Taboada V, Younge B, Goronzy JJ, Weyand CM. Giant cell vasculitis is a T cell-dependent disease. Mol Med 1997;3:530-43.
19. Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ. Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med. In press.
20. Shanahan CM, Weissberg PL. Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 1998;18:333-8.
21. Rupnick MA, Carey A, Williams SK. Phenotypic diversity in cultured cerebral microvascular endothelial cells. In Vitro Cell Dev Biol 1988;24:435-44.
22. Archer SL. Diversity of phenotype and function of vascular smooth muscle cells. J Lab Clin Med 1996;127:524-9.
23. Cid MC, Font C, Coll-Vinent B, Grau JM. Large vessel vasculitides. Curr Opin Rheumatol 1998;10:18-28.
24. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975;83:806-12.
25. Brack A, Martinez-Taboada V, Stanson AW, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42:311-7.
26. Wagner AD, Goronzy JJ, Weyand CM. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis: evidence for two components of the disease. J Clin Invest 1994;94:1134-40.
27. Weyand CM, Wagner AD, Björnsson J, Goronzy JJ. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest 1996;98:1642-9.
28. Wagner AD, Björnsson J, Bartley GB, Goronzy JJ, Weyand CM. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol 1996;148:1925-33.
29. Petursdottir V, Nordborg E, Nordborg C. Atrophy of the aortic media in giant cell arteritis. APMIS 1996;104:191-8.
30. Nikkari ST, Hoyhtya M, Isola J, Nikkari T. Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996;149:1427-33.
31. Rittner HL, Kaiser M, Brack A, Szweda LI, Goronzy JJ, Weyand CM. Tissue destructive macrophages in giant cell arteritis. Circ Res. In press.
32. Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM. Tissue defense mechanisms in vasculitis: aldose reductase functions as a detoxification system for lipid peroxidation products. J Clin Invest. In press.
33. Most J, Spotl L, Mayr G, Gasser A, Sarti A, Dierich MP. Formation of multinucleated giant cells in vitro is dependent on the stage of monocyte to macrophage maturation. Blood 1997;89: 662-71.
34. Poli G, Dianzani MU, Cheeseman KH, Slater TF, Lang J, Esterbauer H. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem J 1985;227:629-38.
35. Uchida K, Szweda LI, Chae HZ, Stadtman ER. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci U S A 1993;90:8742-6.
36. Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998;7:238-58.
37. Evans JM, Bowles CA, Björnsson J, Mullany CJ, Hunder GG. Thoracic aortic aneurysm and rupture in giant cell arteritis: a descriptive study of 41 cases. Arthritis Rheum 1994;37:1539-47.
38. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med 1995;122:502-7.
39. Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997;22:251-6.
40. Bohren KM, Bullock B, Wermuth B, Gabbay KH. The aldo-keto reductase superfamily: cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem 1989;264: 9547-51.
41. Vander JD, KoIb NS, Vander JT, Chino J, Martinez FJ, Hunsaker LA, et al. Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta 1995;1249:117-26.
42. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
43. Dzau VJ. Pathobiology of atherosclerosis and plaque complications. Am Heart J 1994;128:1300-4.
44. Mehta JL, Saldeen TG, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31:1217-25.
45. Shah PK. Pathophysiology of plaque rupture and the concept of plaque stabilization. Cardiol Clin 1996;14:17-29.
46. Shah PK. New insights into the pathogenesis and prevention of acute coronary syndromes. Am J Cardiol 1997;79:17-23.
47. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-73.
48. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-71.
49. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
50. Fuster V, Lewis A. Conner Memorial Lecture - mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994;90:2126-46.
51. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-63.
52. De Feyter PJ, Ozaki Y, Baptista J, Escaned J, Di Mario C, de Jaegere PP, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina: a study with intracoronary angioscopy and ultrasound. Circulation 1995;92:1408-13.
53. Tabata H, Mizuno K, Arakawa K, Satomura K, Shibuya T, Kurita A, et al. Angioscopic identification of coronary thrombus in patients with postinfarction angina. J Am Coll Cardiol 1995;25: 1282-5.
54. Ghanchi FD, Dutton GN. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol 1997;42:99-123.
55. Amano J, Ishiyama S, Nishikawa T, Tanaka H, Nagai R, Marumo F, et al. Proliferation of smooth muscle cells in acute allograft vascular rejection. J Thorac Cardiovasc Surg 1997;113:19-25.
56. Callow AD. Molecular biology of graft occlusion. Curr Opin Cardiol 1995;10:569-76.
57. Faxon DP, Coats W, Currier J. Remodeling of the coronary artery after vascular injury. Prog Cardiovasc Dis 1997;40:129-40.
58. Raines EW, Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 1993;69 Suppl 1:S30-7.
59. Ross R. Cellular and molecular studies of atherogenesis. Atherosclerosis 1997;131 Suppl:S3-4.
60. Wilcox JN, Scott NA. Potential role of the adventitia in arteritis and atherosclerosis. Int J Cardiol 1996;54 Suppl:S21-35.
61. Barker SG, Talbert A, Cottam S, Baskerville PA, Martin JF. Arterial intimai hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler Thromb 1993;13:70-7.
62. Barker SG, Tilling LC, Miller GC, Beesley JE, Fleetwood G, Stavri GT, et al. The adventitia and atherogenesis: removal initiates intimai proliferation in the rabbit which regresses on generation of a 'neoadventitia.' Atherosclerosis 1994;105:131-44.
63. Ross R. Platelet-derived growth factor. Lancet 1989;1:1179-82.
64. Betsholtz C, Raines EW. Platelet-derived growth factor: a key regulator of connective tissue cells in embryogenesis and pathogenesis. Kidney Int 1997;51:1361-9.
65. Chan P, Munro E, Patel M, Betteridge L, Schachter M, Sever P, et al. Cellular biology of human intimai hyperplastic stenosis. Eur J Vasc Surg 1993;7:129-35.
66. Dirks RP, Bloemers HP. Signals controlling the expression of PDGF. Mol Biol Rep 1995;22:1-24.
67. Alpers CE, Davis CL, Barr D, Marsh CL, Hudkins KL. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. Am J Pathol 1996;148:439-51.
68. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990;248:1009-12.
69. Wolinsky H, Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res 1967; 20:409-21.
70. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91: 977-85.
71. Miller JW. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol 1997;151:13-23.
72. Hughes SE, Hall PA. Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. Cardiovasc Res 1993;27: 1199-203.
73. Klein S, Roghani M, Rifkin DB. Fibroblast growth factors as angiogenesis factors: new insights into their mechanism of action. EXS 1997;79:159-92.
74. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-61.